Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167479 · ClinicalTrials.gov registry record · Phase 4
A Study of Risperidone Monotherapy in Bipolar Anxiety
A Phase 4 study of Bipolar Disorder and Generalized Anxiety Disorder, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT00167479: Completed Phase 4 study of Bipolar Disorder and Generalized Anxiety Disorder, sponsored by University of South Florida.
NCT00167479 is a Phase 4 study of Bipolar Disorder and Generalized Anxiety Disorder that has completed, run by University of South Florida. The registered enrollment target is 60 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00167479, a Phase 4 study of Bipolar Disorder and Generalized Anxiety Disorder, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
The specific aim of this study is to evaluate the efficacy, tolerability, and safety of risperidone monotherapy in the treatment of ambulatory bipolar disorder with comorbid lifetime panic disorder or generalized anxiety disorder and current at least moderately severe anxiety.
Conditions Studied
Interventions
- DRUG risperidone (Risperdal)
Study Locations (3)
Florida
- University of South Florida Psychiatry Center - Tampa
Ohio
- University of Cincinatti - Cincinnati
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2003-09 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
What the finished NCT00167479 record still lists
NCT00167479 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (82% lower).
The record links to 3 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which risperidone (Risperdal) is the first listed.
NCT00167479 reports a single indexed study location in Florida, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT00167479 about?
NCT00167479 is a clinical study titled "A Study of Risperidone Monotherapy in Bipolar Anxiety". The specific aim of this study is to evaluate the efficacy, tolerability, and safety of risperidone monotherapy in the treatment of ambulatory bipolar disorder with comorbid lifetime panic disorder or generalized anxiety disorder and current at least moderately severe anxiety.
What is the current status of trial NCT00167479?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2003-09. Estimated completion is 2006-09.
What conditions does trial NCT00167479 study?
This clinical trial studies the following conditions: Bipolar Disorder, Generalized Anxiety Disorder, Panic Disorder.
What interventions are being tested in trial NCT00167479?
The interventions under investigation include: risperidone (Risperdal) (DRUG).
Who is sponsoring clinical trial NCT00167479?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00167479 being conducted?
This trial has 3 study locations across Florida, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00167479's enrollment target sits among peer trials
60 88th of 162 higher than 68 of 162 other Bipolar Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
-
FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
COMPLETED · Phase 4
-
Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
COMPLETED · Phase 4
-
Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
COMPLETED · Phase 4
-
Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence
COMPLETED · Phase 4
-
Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia